Annette Marie Orsborn

Title: The Remarkable Innovations of Annette Marie Orsborn

Introduction: Annette Marie Orsborn, an accomplished inventor based in Hallett Cove, Australia, has made significant contributions in the field of biotechnology. With a total of three patents to her name, she has focused her research on the important area of enzyme deficiencies, particularly her groundbreaking work on alpha-L-iduronidase.

Latest Patents: Annette's latest patent, titled "Synthetic α-L-iduronidase and genetic sequences encoding same," relates to the enzyme α-L-iduronidase and its corresponding genetic sequences. This patent outlines an isolated nucleic acid molecule that encodes or complements a sequence that encodes a mammalian α-L-iduronidase or its fragments and derivatives. The recombinant enzyme derived from this invention is instrumental in the investigation, diagnosis, and treatment of subjects experiencing α-L-iduronidase deficiency.

Career Highlights: Annette's professional journey is deeply rooted in her role at the Women's and Children's Hospital, where she collaborates with a team of innovative professionals dedicated to advancing medical science. Her work prominently features the intersection of technology and medicine, propelling her forward as a key figure in her field.

Collaborations: Throughout her career, Annette has collaborated with notable colleagues such as Donald Stewart Anson and Paul Victor Nelson. Together, they have worked toward enhancing the understanding and treatment of genetic disorders linked to enzyme deficiencies.

Conclusion: Annette Marie Orsborn stands out as an influential inventor within her field. Through her innovative patents and collaborative efforts, she continues to pave the way for advancements in diagnosing and treating genetic disorders, exemplifying the impact of dedicated research and invention.